Thursday, December 05, 2019

Finnish-Kenyan AIDS drug aims for global market

A Kenya-based pharmaceutical company in Finnfund’s investment portfolio has gained WHO approval for an HIV drug which now opens access to the giant UN and Global Fund market.

Development Today is a subscription-based online journal. To subscribe click here.

If you are already a subscriber to Development Today please log in.

Would you like to know more about Development Today? Click here.